Listing & Compliance Notices

Stablecoin Development Corp received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“April 18, 2024, NovaBay Pharmaceuticals, Inc. (the “ Company ”) received a notification (“ Deficiency Letter ”) from the NYSE American LLC (the “ NYSE American ”) stating that the Company is not in compliance with the minimum stockholders’ equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the “ Company Guide ”) requiring stockholders’ equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and $6.0 million or more if the Company has reported losses”

ZW Data Action Technologies Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2024, ZW Data Action Technologies Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic rep”

LIPELLA PHARMACEUTICALS INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 17, 2024, Lipella Pharmaceuticals Inc. (the “Company”) received a letter (the “Nasdaq Letter”) from the Nasdaq Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for the last 30 consecutive business days, the Company was not in compliance with the requirement to maintain a minimum bid price of $1.00 per share of its Common Stock, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasdaq Let”

BEASLEY BROADCAST GROUP INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“October 13, 2023, the Company received a written notice (the “Notice”) from Nasdaq’s Listing Qualifications Department notifying the Company that, for the last 30 consecutive business days, the bid price for the Common Stock had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days (the “Initial Compliance Period”) to regain compliance with the Minimum Bid Price Re”

XCel Brands, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5810(c)(3)(A), 5810(c)(3)(A)(ii)).

“April 16, 2024, Xcel Brands, Inc. (the “Company”), received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the minimum bid price per share for its common stock fell below $1.00 for a period of 30 consecutive business days. Therefore, the Company did not meet the minimum bid price requirement set forth in the Nasdaq Listing Rules. ​ The letters also state that pursuant to Nasdaq Listing Rules 5810(c)(3)(A), the Company will be provided 180 calendar days to regain compliance with the minimum bid price requirement, or until Oct”

LIFECORE BIOMEDICAL, INC. DE received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“and November 29, 2023 (the “Q1 Form 10-Q” and “Q2 Form 10-Q,” respectively, and together with the Q3 Form 10-Q, the “Filings”) with the Securities and Exchange Commission (the “SEC”), the Company continues not to be in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), and that the Nasdaq Hearings Panel would consider the delinquency in the filing of the Q3 Form 10-Q in rendering its determination regarding the Company’s continued listing on Nasdaq Global Select Market . The Notice has no immediate effect on the listing or trading”

ProSomnus, Inc. received a nasdaq deficiency notice notice regarding minimum bid price.

“April 18, 2024 and that Nasdaq would file a Form 25 with the Securities and Exchange Commission to delist the Company’s common stock and warrants from Nasdaq. The delisting will be effective 10 days after the filing of the Form 25. In light of the impending delisting, the Company is taking steps to resume the quoting and trading of its common stock and warrants on the over the counter “OTC” market under the symbols OSAP and OSAPW, respectively. There can be no assurance that trading in the Company’s securities will commence or continue on the OTC or other market or that such trading will occur”

PHOENIX MOTOR INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 17, 2024, Phoenix Motor Inc. (the “Company”) received a letter (the “Deficiency Letter”) from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the Company’s Form 10-K for the year ended December 31, 2023 (the “Form 10-K”), the Company was not in compliance with the requirement to maintain a minimum of $2,500,000 in stockholders’ equity. In the Form 10-K, the Company reported stockholders’ equity of ($4,839,000), which is below the minimum stockholders’ equity required for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1). A”

Alset Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 15, 2024, Alset Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company’s bid price was below the minimum $1 required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq has provided the Company with 180 calendar days, or until October 12, 2024, (”

Adamas One Corp. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 11, 2024, the Company received notification that it had failed to regain compliance with the Rule and is not eligible for a second 180 day compliance period because of its failure to comply with the $5 million minimum stockholders’ equity initial listing requirement for the period ended December 31, 2023. Unless the Company timely requests a hearing before an independent Nasdaq Hearings Panel (the “Panel”), the Company’s securities will be subject to delisting. Accordingly, the Company will request a hearing before the Panel. The hearing request will automatically stay any suspension or”

Roth CH Acquisition Co. received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2), 5620(a)).

“January 29, 2024, the Company received a notice from Nasdaq that the Company was not in compliance with Nasdaq Listing Rule 5620(a), which requires that Nasdaq-listed companies hold an annual meeting of shareholders within twelve months of their fiscal year end because the Company did not hold an annual meeting of shareholders within twelve months of its fiscal year ended December 31, 2022. Following the delisting, the Company expects to have its Class A Ordinary Shares, Units, and Warrants quoted on a market operated by OTC Markets Group Inc. (the “OTC”) so that a trading market may continue”

Edible Garden AG Inc received a nasdaq noncompliance notice notice regarding shareholders (rules 5550(a)(4)).

“April 11, 2024, Edible Garden AG Incorporated (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company does not comply with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Rule”) because: (i) the Company’s stockholders’ deficit of $288,000, as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, is less than the required minimum of $2,500,000; and (ii) as of”

Edible Garden AG Inc received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 11, 2024, Edible Garden AG Incorporated (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company does not comply with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Rule”) because: (i) the Company’s stockholders’ deficit of $288,000, as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, is less than the required minimum of $2,500,000; and (ii) as of”

SCWorx Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2024, the Nasdaq Stock Market notified the Registrant that it has failed to satisfy a a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1), because the Registrant did not file its Annual Report on Form 10-K by the extended due date of April 15, 2024. The Registrant is working with its independent registered public accounting firm to complete the audit of its financial statements as expeditiously as possible, following which the Registrant will promptly file its Annual Report on Form 10-K. The Registrant intends to notify the Nasdaq of this plan to rectify the exist”

RiskOn International, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5110(a), 5635(b), 5640, 5550(b)(1)).

“April 12, 2024, RiskOn International, Inc., a Nevada corporation (the “ Company ”) received a written notice from the Nasdaq Hearings Panel (the “ Panel ”) that the Panel had determined to delist the Company’s common stock (“ Common Stock ”) from The Nasdaq Capital Market (the “ Nasdaq Capital Market ”). The Panel reached its decision to delist the Common Stock from the Nasdaq Capital Market for violating Nasdaq Listing Rule 5110(a) and Listing Rule 5635(b) as a result of the acquisition of BitNile.com, Inc., which closed on March 6, 2023. In addition, the Panel concluded that the Company’s mu”

Venus Concept Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 11, 2024, Venus Concept Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) stating that for 32 consecutive business days the Company’s common stock (the “Common Stock”) did not maintain a minimum closing bid price of $1.00 per share (“Minimum Bid Price Requirement”) as required for continued listing under Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing of the Common Stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, o”

Acorda Therapeutics, Inc. received a nasdaq delisting notice notice regarding other.

“April 15, 2024, Acorda Therapeutics, Inc. (the “Company”) issued a press release announcing that the Company’s common stock ceased trading on the Nasdaq Stock Market on April 12, 2024 and began trading on the Pink Open Market under the symbol “ACORQ.” A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.”

BranchOut Food Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 11, 2024, the Company received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) (the “Rule”) because the stockholders’ equity of the Company of $2,210,476 as of December 31, 2023, as reported in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2024, was below the minimum requirement of $2,500,000. Pursuant to Nasdaq’s Listing Rules, the Company has until May 28, 2024 to submit a plan to regain compliance with the Rule (a “Compliance Plan”). The Company intends to submit a Compliance”

PHOENIX MOTOR INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 12, 2024, Phoenix Motor Inc. (the “Company”) received a letter (the “Deficiency Letter”) from the staff from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company was not in compliance with the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Deficiency Letter has no immediate effect on the listing of the Com”

Agape ATP Corp received a nasdaq compliance regained notice regarding market value (rules 5550(b)(1), 5550(b)(2)).

“April 10, 2024, Nasdaq confirmed that the Company had regained compliance with Rule 5550(b)(1) and that this matter is now closed. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AGAPE ATP CORPORATION Date: April 16, 2024 By: /s/ How Kok Choong Name: How Kok Choong Title: Director, Chairman of the Board of Directors, Chief Executive Officer, Chief Operating Officer and Secretary 3”

DermTech, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).

“April 15, 2024, DermTech, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), closed below the minimum $1.00 per share requirement for continued inclusion under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq rules, the Company has been provided a 180-calendar day compliance pe”

CEA Industries Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 9, 2024, the Company received a second notice from Nasdaq indicating that the Listings Qualifications Staff will be delisting the shares of common stock and common stock warrants from Nasdaq at the opening of business on April 18, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which would remove the Company’s securities from listing and registration on The Nasdaq Stock Market. On April 16, 2024, the Company filed an appeal with Nasdaq’s Listing Committee, which temporarily stays the delisting of the Company’s securities and the filing of the Form 25-NS”

INNO HOLDINGS INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 12, 2024, Inno Holdings Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market notifying the Company that, because the closing bid price for its common stock has been below $1.00 per share for 30 consecutive business days, it no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), and Listing Rule 5810(c)(3)(A) provides that a failure to meet the Minimum Bid Pri”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5250(c)(1)).

“April 11, 2024, Inspire Veterinary Partners, Inc. (the “Company”) received a staff determination from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’ equity of ($788,259) as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission, the Company does not meet the alternatives of market value of listed securities or net income from continuing operations. As such, the Company no longer complies with Nasdaq’s Listing Rule (the “Rule”). Accordingly, this matter se”

Technology & Telecommunication Acquisition Corp received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“April 10, 2024, Technology and Telecommunication Acquisition Corporation (“TETE”) received a letter (the “Notice”) from the Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that TETE no longer complies with the requirements of Nasdaq Listing Rule 5450(a)(2) (the “Rule”) for continued listing on the Nasdaq Global Market. Under the Rule, TETE is required to maintain at least 400 total holders (the “Total Holder Requirement”). The Notice indicates that TETE has 45 calendar days (the “Deadline”) to submit a plan (the “Compliance Plan”) to regain compliance”

Sonendo, Inc. received a nyse delisting notice notice regarding other.

“April 11, 2024, the Company withdrew its request for an appeal. As a result, the NYSE notified the Company of its intention to apply to the Securities and Exchange Commission for delisting of the Company’s common stock, which will remove the common stock from listing and registration on the NYSE. The Company’s common stock currently trades under the symbol “SONX” on the on the OTCQX, which is operated by OTC Markets Group Inc. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned”

ENvue Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 10, 2024, NanoVibronix, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business days between February 27, 2024, to April 9, 2024, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until Oc”

EAGLE PHARMACEUTICALS, INC. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“April 8, 2024, Eagle Pharmaceuticals , Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with t”

ConnectM Technology Solutions, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“April 10, 2024, MCAC received a letter (the “Notice”) from the Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that MCAC no longer complies with the requirements of Nasdaq Listing Rule 5450(a)(2) (the “Rule”) for continued listing on the Nasdaq Global Market. Under the Rule, MCAC is required to maintain at least 400 total holders (the “Total Holder Requirement”). The Notice indicates that MCAC has 45 calendar days (the “Deadline”) to submit a plan (the “Compliance Plan”) to regain compliance with the Rule. If Nasdaq accepts the Compliance Plan, Nasdaq”

ClimateRock received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“April 10, 2024, ClimateRock (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Company’s public holders of its Class A ordinary shares (“Public Holders”) were below the 400 Public Holders minimum requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(2) (the “Public Holders Requirement”). The notifications received have no immediate effect on the Company’s Nasdaq listing. The Nasdaq rules provide the Company 45 calendar days to”

Eightco Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5810(c)(3)(A)).

“March 28, 2024, the Company received a staff determination letter (the “Staff Determination Letter”) from Nasdaq informing the Company that the Company had not regained compliance with the Minimum Bid Price Rule. The Staff Determination Letter noted that unless the Company requested an appeal of the staff’s determination, the Company’s securities would be scheduled for delisting from The Nasdaq Capital Market. On April 9, 2024, the Company received a second staff determination letter (the “Additional Staff Determination Letter”) from Nasdaq indicating that the Company was also not in complianc”

Mobile Global Esports, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“k (the “Common Stock”), for the last 30 consecutive business days, had closed below the minimum $1.00 per share and, as a result, the Company is not in compliance with the $1.00 minimum bid price requirement for the continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Company was provided an initial period of 180 calendar days, or until October 9, 2023 to regain compliance with the Minimum Bid Price Rule. Subsequently, on October 10, 2023, the Company was provided an additional 180 calendar day compliance period, or”

ExcelFin Acquisition Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“April 10, 2024, ExcelFin Acquisition Corp., a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the “Minimum Total Holders Rule”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s sec”

byNordic Acquisition Corp received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“April 10, 2023, the Company received a letter (the “ Letter ”) from the staff at The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the Company no longer complies with the requirements of Nasdaq Listing Rule 5450(a)(2) (the “ Rule ”) for continued listing on Nasdaq. Under the Rule, the Company is required to maintain at least 400 total holders (the “ Total Holder Requirement ”). The Notice indicates that the Company has 45 calendar days (the “ Deadline ”) to submit a plan (the “ Compliance Plan ”) to regain compliance with the Rule. If Nasdaq accepts the Compliance Plan, Nasda”

Leafly Holdings, Inc. /DE received a nasdaq deficiency notice notice regarding other (rules 5550).

“April 9, 2024, Leafly Holdings, Inc. (the "Company") received a notification (the "Notice") from the Listing Qualifications Staff (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it no longer complies with Nasdaq's requirements contained in Nasdaq Listing Rule 5550 for companies traded on the Nasdaq Capital Market (the "Capital Market"). Nasdaq Listing Rule 5550 requires a company listed on the Capital Market to continuously meet at least one of the following requirements set forth in Nasdaq Listing Rule 5550(b) (the "Continued Listing Standards"): Continued L”

STRYVE FOODS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 9, 2024, Stryve Foods, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department indicating that the Company was not in compliance with Nasdaq’s Listing Rule 5550(b)(1) because the Company’s stockholders’ equity for the year ended December 31, 2023, as reported in the Company’s Form 10-K, was below the minimum stockholders’ equity requirement of $2,500,000 (the “Stockholders’ Equity Requirement”). The notice had no immediate effect on the Company’s continued listing on Nasdaq, subject to the Company’s compliance with the other continued listing r”

Aclarion, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 8, 2024, Aclarion, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per”

Minerva Neurosciences, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“April 10, 2024, Minerva Neurosciences, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with Nasdaq’s Listing Rule 5550(b)(2), as the market value of listed securities (the “MVLS requirement”) for the Company’s common stock had been below the minimum MVLS requirement of $35,000,000 for the last 31 consecutive business days. The notification of noncompliance indicated that the Company would be provided 180 calendar days in which to regain compliance with the MVLS requirement. The Notice provides the Company wi”

SOBR Safe, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“equity for continued listing (the “Stockholders’ Equity Rule”). The Company’s Annual Report on Form 10-K for the period ended December 31, 2023 reported stockholders’ equity of $1,982,537. In situations where a company does not comply with the Stockholders’ Equity Rule, the Staff may determine whether such company has a market value of listed securities of $35”

Sintx Technologies, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).

“April 8, 2024, the Company received a new notification letter from the Staff notifying the Company that, as of April 5, 2024, the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days and that, consistent with Nasdaq Listing Rule 5810(c)(3)(A)(iii), the Staff has determined to delist the Company’s common stock from The Nasdaq Capital Market. The notice further provides that the Company has until April 15, 2024, to request a hearing before an independent Hearings Panel (the “Panel”). The Company plans to timely request a hearing before the Panel, which”

Sintx Technologies, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(A)(iii)).

“October 20, 2023, the Company received a notification letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock was below $1.00 per share for 30 consecutive trading days, the Company is not currently in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided”

VACCINEX, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 11, 2024, Vaccinex, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the financial statements contained in its Form 10-K for the year-ended December 31, 2023, the Company no longer complies with the requirement under Nasdaq Listing Rule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders’ equity for continued listing on the Nasdaq Capital Market (the “Equity Standard”) or the alternative requirements of having a market value of listed securities of $35 million”

URBAN ONE, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 8, 2024 it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with requirements of Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “2023 Form 10-K”), with the Securities and Exchange Commission (“SEC”). Pursuant to the Nasdaq Listing Rules, the Company has been afforded 60 calendar days, or until June 7, 2024, to submit a plan to regain compliance. If Nasdaq accepts the c”

Triller Group Inc. received a nasdaq compliance regained notice regarding late filing (rules 5550(b)(2), 5550(b)(1)).

“December 31, 2023 filed on March 28, 2024, the Company reported shareholders’ equity of $8,102,771. On April 10, 2024, Nasdaq confirmed that the Company had regained compliance with Rule 5550(b)(1) and that this matter is now closed. 1 SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AGBA GROUP HOLDING LIMITED By: /s/ Shu Pei Huang, Desmond Name: Shu Pei Huang, Desmond Title: Acting Group Chief Financial Officer Dated: April 11, 2024 2”

Motus GI Holdings, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“April 5, 2024, Motus GI Holdings, Inc., a Delaware corporation (the “Company”), received a notification letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Staff had determined that the bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), had closed at less than $1 per share over the previous 30 consecutive business days, and, as a result, does not comply with Listing Rule 5550(a)(2). The Letter indicated that, as a result of the 1:20 reverse stock split effected on July 25”

CIMG Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)).

“April 9, 2024 letter from Nasdaq granting an extension of time to regain compliance with Nasdaq Listing Rule 5550(b) until June 14, 2024. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 23, 2024, NuZee, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on The Nasdaq Capi”

CIMG Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“January 23, 2024, NuZee, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on The Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity Requirement). Pursuant to the Notice, Nasdaq gave the Company 45 calendar days to submit to Nasdaq a plan to regain compliance. The Company timely submitted i”

Akari Therapeutics Plc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 5, 2024, Akari Therapeutics, Plc (the “Company”) received a letter (“Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Capital Market (“Nasdaq”) notifying the Company that the Company’s stockholders’ equity as reported in its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”) is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity”

Onyx Acquisition Co. I received a nasdaq deficiency notice notice regarding other (rules 5450(b)(2)(B)).

“April 5, 2024, Onyx Acquisition Co. I (the “Company”) received a written notice (the “MVPHS Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it did not meet the $15,000,000 minimum market value of publicly held shares required to maintain continued listing as set forth in Nasdaq’s Listing Rule 5450(b)(2)(C) (the “MVPHS Rule”) for the 30-business day period ended April 3, 2024. Under applicable Nasdaq rules, the Company will have 180 calendar days from the date of the MVPHS Notice, or until October 2, 2024, to”

Onyx Acquisition Co. I received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“April 5, 2024, Onyx Acquisition Co. I (the “Company”) received a written notice (the “MVPHS Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it did not meet the $15,000,000 minimum market value of publicly held shares required to maintain continued listing as set forth in Nasdaq’s Listing Rule 5450(b)(2)(C) (the “MVPHS Rule”) for the 30-business day period ended April 3, 2024. Under applicable Nasdaq rules, the Company will have 180 calendar days from the date of the MVPHS Notice, or until October 2, 2024, to”